Published in Circulation on December 01, 1995
Pleiotropic effects of statins. Annu Rev Pharmacol Toxicol (2005) 5.30
Platelet CD36 links hyperlipidemia, oxidant stress and a prothrombotic phenotype. Nat Med (2007) 4.11
HMG-CoA reductase inhibitors (statins) increase endothelial progenitor cells via the PI 3-kinase/Akt pathway. J Clin Invest (2001) 4.11
Scavenger receptor BI modulates platelet reactivity and thrombosis in dyslipidemia. Blood (2010) 1.60
Effects of statins on 3-hydroxy-3-methylglutaryl coenzyme a reductase inhibition beyond low-density lipoprotein cholesterol. Am J Cardiol (2005) 1.55
Monocyte tissue factor-dependent activation of coagulation in hypercholesterolemic mice and monkeys is inhibited by simvastatin. J Clin Invest (2012) 1.51
The use of HMG Co-A reductase inhibitors following acute myocardial infarction in hospital practice. Postgrad Med J (1998) 1.37
Oxidized high-density lipoprotein inhibits platelet activation and aggregation via scavenger receptor BI. Blood (2007) 1.19
Inflammatory and thrombotic mechanisms in coronary atherosclerosis. Heart (2003) 1.13
Statins and cardiovascular diseases: from cholesterol lowering to pleiotropy. Curr Pharm Des (2009) 1.09
Regulation of platelet function by class B scavenger receptors in hyperlipidemia. Arterioscler Thromb Vasc Biol (2010) 1.03
Nitric oxide, atherosclerosis and the clinical relevance of endothelial dysfunction. Heart Fail Rev (2003) 1.03
L-4F alters hyperlipidemic (but not healthy) mouse plasma to reduce platelet aggregation. Arterioscler Thromb Vasc Biol (2009) 1.00
Contribution of the P2Y12 receptor-mediated pathway to platelet hyperreactivity in hypercholesterolemia. J Thromb Haemost (2011) 0.85
A novel trigger for cholesterol-dependent smooth muscle contraction mediated by the sphingosylphosphorylcholine-Rho-kinase pathway in the rat basilar artery: a mechanistic role for lipid rafts. J Cereb Blood Flow Metab (2015) 0.83
Cholesterol lowering and coronary artery disease: mechanisms of risk reduction. Heart (1998) 0.81
Stimulation of endothelial progenitor cells: a new putative effect of several cardiovascular drugs. Eur J Clin Pharmacol (2009) 0.81
Effects of statins on the secretion of human serum albumin in cultured HepG2 cells. J Biomed Sci (2009) 0.81
Beneficial effects of statins after percutaneous coronary intervention. Eur J Cardiovasc Prev Rehabil (2009) 0.80
The effect of early statin treatment on inflammation and cardiac events in acute coronary syndrome patients with low-density lipoprotein cholesterol. Heart Vessels (2006) 0.79
Effects of Low Dose versus High Dose Statin Therapy on the Changes of Endothelial Function and Carotid Intima-Media Thickness in Patients with Variant Angina. J Cardiovasc Ultrasound (2013) 0.79
Using information theory to assess the communicative capacity of circulating microRNA. Biochem Biophys Res Commun (2013) 0.78
The Myocardial Ischemia Reduction with Acute Cholesterol Lowering (MIRACL) trial: a new frontier for statins? Curr Control Trials Cardiovasc Med (2001) 0.78
Effect of pretreatment of ezetimibe/simvastatin on arterial healing and endothelialization after drug-eluting stent implantation in a porcine coronary restenosis model. Korean Circ J (2015) 0.78
Functional genomics of the human high-density lipoprotein receptor scavenger receptor BI: an old dog with new tricks. Curr Opin Endocrinol Diabetes Obes (2013) 0.78
Hepatic RNA Interference: Delivery by Synthetic Vectors. Drug Deliv Transl Res (2014) 0.77
Role of statins in coronary artery disease. Chonnam Med J (2013) 0.77
Impact of 3'UTR genetic variants in PCSK9 and LDLR genes on plasma lipid traits and response to atorvastatin in Brazilian subjects: a pilot study. Int J Clin Exp Med (2015) 0.77
Supplementation of a standardized extract from Phyllanthus emblica improves cardiovascular risk factors and platelet aggregation in overweight/class-1 obese adults. J Med Food (2015) 0.76
Argan oil prevents prothrombotic complications by lowering lipid levels and platelet aggregation, enhancing oxidative status in dyslipidemic patients from the area of Rabat (Morocco). Lipids Health Dis (2013) 0.75
Fenofibrate/simvastatin fixed-dose combination in the treatment of mixed dyslipidemia: safety, efficacy, and place in therapy. Vasc Health Risk Manag (2017) 0.75
Effect of pioglitazone on the abrogated cardioprotective effect of ischemic preconditioning in hyperlipidemic rat heart. Indian J Pharmacol (2016) 0.75
Endothelial progenitor cells: Exploring the pleiotropic effects of statins. World J Cardiol (2017) 0.75
Correction of increased thrombogenic potential with cholesterol reduction is mainly due to vascular wall. Circulation (1997) 0.75
[Non-lipid effects of statins: myth or fact?]. Wien Med Wochenschr (2003) 0.75
Short-term therapy with relatively low-dose cerivastatin improves endothelial function independently of its lipid-lowering effect: Evaluation of brachial artery vasodilatation using B-mode ultrasound imaging. J Med Ultrason (2001) (2002) 0.75
TLR2 Plays a Key Role in Platelet Hyperreactivity and Accelerated Thrombosis Associated with Hyperlipidemia. Circ Res (2017) 0.75
Effects of atorvastatin on early recurrent ischemic events in acute coronary syndromes: the MIRACL study: a randomized controlled trial. JAMA (2001) 9.16
Aggressive lipid-lowering therapy compared with angioplasty in stable coronary artery disease. Atorvastatin versus Revascularization Treatment Investigators. N Engl J Med (1999) 5.09
Effects of estrogen replacement on the progression of coronary-artery atherosclerosis. N Engl J Med (2000) 4.84
Isolation of Clostridium difficile from the environment and contacts of patients with antibiotic-associated colitis. J Infect Dis (1981) 3.76
Serum HIV-1 RNA levels and time to development of AIDS in the Multicenter Hemophilia Cohort Study. JAMA (1996) 3.50
Emergence of viruses resistant to neutralization by V3-specific antibodies in experimental human immunodeficiency virus type 1 IIIB infection of chimpanzees. J Virol (1990) 3.35
Mapping the cleavage site in protein synthesis initiation factor eIF-4 gamma of the 2A proteases from human Coxsackievirus and rhinovirus. J Biol Chem (1993) 2.70
Foot-and-mouth disease virus leader proteinase: purification of the Lb form and determination of its cleavage site on eIF-4 gamma. J Virol (1994) 2.41
A quantification of human cells using an ERV-3 real time PCR assay. J Virol Methods (2001) 2.20
Antioxidant vitamins and the risk of carotid atherosclerosis. The Perth Carotid Ultrasound Disease Assessment study (CUDAS). J Am Coll Cardiol (2001) 2.12
Structural implications of drug-resistant mutants of HIV-1 protease: high-resolution crystal structures of the mutant protease/substrate analogue complexes. Proteins (2001) 2.08
Risk of human immunodeficiency virus (HIV-1) infection among laboratory workers. Science (1988) 1.97
Hyperhomocysteinemia but not the C677T mutation of methylenetetrahydrofolate reductase is an independent risk determinant of carotid wall thickening. The Perth Carotid Ultrasound Disease Assessment Study (CUDAS) Circulation (1999) 1.90
Glucose and insulin abnormalities relate to functional capacity in patients with congestive heart failure. Eur Heart J (2000) 1.88
Sequential molecular abnormalities are involved in the multistage development of squamous cell lung carcinoma. Oncogene (1999) 1.83
Left-to-right atrial shunting after percutaneous mitral valvuloplasty. Incidence and long-term hemodynamic follow-up. Circulation (1990) 1.77
Aspirin versus heparin to prevent myocardial infarction during the acute phase of unstable angina. Circulation (1993) 1.74
Incremental doses of dobutamine induce a biphasic response in dysfunctional left ventricular regions subtending coronary stenoses. Circulation (1995) 1.68
Perinatal intervention trial in Africa: effect of a birth canal cleansing intervention to prevent HIV transmission. Lancet (1996) 1.62
Sexual transmission of human T-lymphotropic virus type I (HTLV-I). Ann Intern Med (1989) 1.57
Genetic instability in human ovarian cancer cell lines. Proc Natl Acad Sci U S A (1994) 1.56
Rationale and design of the Myocardial Ischemia Reduction with Aggressive Cholesterol Lowering (MIRACL) study that evaluates atorvastatin in unstable angina pectoris and in non-Q-wave acute myocardial infarction. Am J Cardiol (1998) 1.55
Detection of dysplasia and carcinoma in situ with a lung imaging fluorescence endoscope device. J Thorac Cardiovasc Surg (1993) 1.54
The risks associated with short-term placebo-controlled antihypertensive clinical trials: a descriptive meta-analysis. J Hum Hypertens (2008) 1.51
Adenovirus-based p53 gene therapy in ovarian cancer. Gynecol Oncol (1995) 1.49
Symptom-limited versus low level exercise testing before hospital discharge after myocardial infarction. J Am Coll Cardiol (1992) 1.48
A randomized controlled trial of smoking cessation counseling after myocardial infarction. Prev Med (2000) 1.47
Five-color-based high-information-content fingerprinting of bacterial artificial chromosome clones using type IIS restriction endonucleases. Genomics (2001) 1.40
Observation of B(0)(s)-->Psi(2S)Phi and measurement of the ratio of branching fractions Beta(B(0)(s)-->Psi(2S)Phi)/Beta(B(0)(s)-->J/PsiPhi). Phys Rev Lett (2006) 1.40
Allelotyping demonstrates common and distinct patterns of chromosomal loss in human lung cancer types. Genes Chromosomes Cancer (1998) 1.38
Reactivation of unstable angina after the discontinuation of heparin. N Engl J Med (1992) 1.36
Long-term results after early primary repair of tetralogy of Fallot. J Thorac Cardiovasc Surg (2001) 1.35
Uremic cardiomyopathy--effect of hemodialysis on left ventricular function in end-stage renal failure. N Engl J Med (1980) 1.33
Precision top-quark mass measurement at CDF. Phys Rev Lett (2012) 1.30
Blood collection on filter paper: a practical approach to sample collection for studies of perinatal HIV transmission. J Acquir Immune Defic Syndr Hum Retrovirol (1997) 1.30
Identifying human herpesvirus 8 infection: performance characteristics of serologic assays. J Acquir Immune Defic Syndr (2000) 1.28
Measurement of the cross section for prompt isolated diphoton production using the full CDF run II data sample. Phys Rev Lett (2013) 1.22
Detection of early lung cancer using low dose Photofrin II. Chest (1990) 1.17
Quantitative proviral DNA and antibody levels in the natural history of HTLV-I infection. J Infect Dis (1999) 1.15
Cigarette smoking acutely increases platelet thrombus formation in patients with coronary artery disease taking aspirin. Circulation (1995) 1.13
Plasma lipoproteins and progression of coronary artery disease evaluated by angiography and clinical events. Circulation (1993) 1.13
Measurement of the WW + WZ production cross section using the lepton + jets final state at CDF II. Phys Rev Lett (2010) 1.12
Is thrombolytic therapy striking out in unstable angina? Circulation (1992) 1.11
First observation of the decay Bs0-->Ds-Ds+ and measurement of its branching ratio. Phys Rev Lett (2008) 1.11
Efficacy of high dose intravenous heparin for treatment of left ventricular thrombi with high embolic risk. J Am Coll Cardiol (1994) 1.09
Evidence for a particle produced in association with weak bosons and decaying to a bottom-antibottom quark pair in higgs boson searches at the tevatron. Phys Rev Lett (2012) 1.08
Measurement of sigma chi c2 B(chi c2-->J/psi gamma)/sigma chi c1 B(chi c1 -->J/psi gamma) in pp collisions at square root s=1.96 TeV. Phys Rev Lett (2007) 1.07
Is a mechanical or a metabolic approach superior in the treatment of coronary disease? Results of the atorvastatin versus revascularization (AVERT) trial. Eur Heart J (2000) 1.07
Allele-specific chromosome 3p deletions occur at an early stage in the pathogenesis of lung carcinoma. JAMA (1995) 1.07
Effects of dietary supplementation with cod-liver oil on endothelium-dependent responses in porcine coronary arteries. Circulation (1987) 1.07
Precise measurement of the W-boson mass with the CDF II detector. Phys Rev Lett (2012) 1.06
Prognostic role of troponin T versus troponin I in unstable angina pectoris for cardiac events with meta-analysis comparing published studies. Am J Cardiol (1998) 1.05
Impact of new biomarkers of myocardial damage on trends in myocardial infarction hospital admission rates from population-based administrative data. Am J Epidemiol (2008) 1.05
Hepatitis C virus infection in the mothers and infants cohort study. Pediatrics (1998) 1.04
Molecular genetic changes found in human lung cancer and its precursor lesions. Cold Spring Harb Symp Quant Biol (1994) 1.04
Direct measurement of the W production charge asymmetry in pp collisions at square root s=1.96 TeV. Phys Rev Lett (2009) 1.04
Search for long-lived massive charged particles in 1.96 TeV pp collisions. Phys Rev Lett (2009) 1.03
Measurement of d sigma/dM and forward-backward charge asymmetry for high-mass Drell-Yan e(+)e(-) pairs from pp macro collisions at square root of s = 1.8 TeV. Phys Rev Lett (2001) 1.02
An imposed oscillating electrical field improves the recovery of function in neurologically complete paraplegic dogs. J Neurotrauma (1999) 1.02
A specific activity questionnaire to measure the functional capacity of cardiac patients. Am J Cardiol (1996) 1.01
Detection of squamous cell cancer and pre-cancerous lesions by imaging of tissue autofluorescence in the hamster cheek pouch model. Surg Oncol (1992) 1.01
Observation of Bs(0)-Bs(0) oscillations. Phys Rev Lett (2006) 1.00
The influence of pregnancy on human immunodeficiency virus type 1 infection: antepartum and postpartum changes in human immunodeficiency virus type 1 viral load. Am J Obstet Gynecol (1998) 0.99
Detection and localization of early lung cancer by imaging techniques. Chest (1991) 0.98
Prognostic importance of scintigraphic left ventricular cavity dilation during intravenous dipyridamole technetium-99m sestamibi myocardial tomographic imaging in predicting coronary events. Am J Cardiol (1997) 0.98
HPV 16 antibody prevalence in Jamaica and the United States reflects differences in cervical cancer rates. Int J Cancer (1999) 0.98
Detection of early human T-cell lymphotropic virus type I antibody patterns during seroconversion among transfusion recipients. Blood (1991) 0.98
A Pro12Ala polymorphism in the human peroxisome proliferator-activated receptor-gamma 2 is associated with combined hyperlipidaemia in obesity. Eur J Endocrinol (2001) 0.97
Work related assaults. The impact on victims. AAOHN J (1999) 0.97
Allele-specific mutations involved in the pathogenesis of endemic gallbladder carcinoma in Chile. Cancer Res (1995) 0.97
Search for large extra dimensions in final states containing one photon or jet and large missing transverse energy produced in pp collisions at square root[s]=1.96 TeV. Phys Rev Lett (2008) 0.97
Real-time polymerase chain reaction assay for cell-associated HTLV type I DNA viral load. AIDS Res Hum Retroviruses (2000) 0.96
Preoperative coronary artery disease risk stratification based on dipyridamole imaging and a simple three-step, three-segment model for patients undergoing noncardiac vascular surgery or major general surgery. Am J Cardiol (1992) 0.96
Polarizations of J/psi and psi(2S) mesons produced in pp collisions at square root s = 1.96 TeV. Phys Rev Lett (2007) 0.96
Cardiovascular responses to exercise in middle-aged men after 10 days of bedrest. Circulation (1982) 0.96
Altered synchrony and connectivity in neuronal networks expressing an autism-related mutation of neuroligin 3. Neuroscience (2009) 0.95
Non-infectious virus induces cytotoxic T lymphocytes and binds to target cells to permit their lysis. Nature (1977) 0.95
Percutaneous mitral valvuloplasty in surgical high risk patients. J Am Coll Cardiol (1991) 0.95
Measurement of the top-quark mass in all-hadronic decays in pp collisions at CDF II. Phys Rev Lett (2007) 0.95
Examining the molecular genetics of HTLV-I with an infectious molecular clone of the virus and permissive cell culture systems. J Acquir Immune Defic Syndr Hum Retrovirol (1996) 0.95
Interlaboratory agreement among results of human papillomavirus type 16 enzyme-linked immunosorbent assays. J Clin Microbiol (1997) 0.95
Measurement of the strong coupling constant from inclusive jet production at the Tevatron pp collider. Phys Rev Lett (2002) 0.94
Search for gluinos and scalar quarks in pp collisions at square root[s] = 1.8 TeV using the missing energy plus multijets signature. Phys Rev Lett (2002) 0.93
Atypical cutaneous leishmaniasis in Central America: possible interaction between infectious and environmental elements. Trans R Soc Trop Med Hyg (2005) 0.93
Bayesian methods for meta-analysis of causal relationships estimated using genetic instrumental variables. Stat Med (2010) 0.93
Extensive areas of aneuploidy are present in the respiratory epithelium of lung cancer patients. Br J Cancer (1996) 0.93
Is vasospasm related to platelet deposition? Relationship in a porcine preparation of arterial injury in vivo. Circulation (1987) 0.92
Intracellular bile acid transport in rat liver as visualized by electron microscope autoradiography using a bile acid analogue. Am J Physiol (1983) 0.92
Search for a fermiophobic Higgs boson decaying into diphotons in pp[over] collisions at sqrt[s] = 1.96 TeV. Phys Rev Lett (2009) 0.92
Viral variability and serum antibody response in a laboratory worker infected with HIV type 1 (HTLV type IIIB). AIDS Res Hum Retroviruses (1994) 0.92
Comparative effects of halothane, isoflurane, sevoflurane and desflurane on the electroencephalogram of the rat. Lab Anim (2008) 0.92
Lymphocyte subpopulation monitoring in cyclosporine-treated patients following heart transplantation. Ann Thorac Surg (1988) 0.92
Cross-sectional echocardiographic diagnosis of unruptured right sinus of Valsalva aneurysm dissecting into the interventricular septum. Int J Cardiol (1985) 0.91
First measurement of the b-jet cross section in events with a W boson in pp collisions at square root(s) = 1.96 TeV. Phys Rev Lett (2010) 0.91
Successful treatment of severe heart failure caused by idiopathic giant cell myocarditis. Can J Cardiol (1992) 0.91